RPL22L1 is a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma, promoting the growth and metastasis of LUAD cells by inhibiting the MDM2/P53 signaling pathway
Aging · 2024
DOI: 10.18632/aging.206096 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Shigui Xing und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Nanjing Gaochun People’s Hospital, Nanjing 211300, Jiangsu, China. Hauptthemen laut MEDLINE: Ribosomal Proteins, Adenocarcinoma of Lung, Proto-Oncogene Proteins c-mdm2, Biomarkers, Tumor. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Nanjing Gaochun People’s Hospital, Nanjing 211300, Jiangsu, China.
- Scientific Research Center, Beijing ChosenMed Clinical Laboratory Co., Ltd., Beijing 100176, China.
- Department of Pulmonary and Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, Jiangsu, China.
Zitieren
APA
Xing, S., Li, D., & Zhao, Q. (2024). RPL22L1 is a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma, promoting the growth and metastasis of LUAD cells by inhibiting the MDM2/P53 signaling pathway. Aging. https://doi.org/10.18632/aging.206096
Vancouver
Xing S, Li D, Zhao Q. RPL22L1 is a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma, promoting the growth and metastasis of LUAD cells by inhibiting the MDM2/P53 signaling pathway. Aging. 2024. doi:10.18632/aging.206096
BibTeX
@article{Xing2024,
author = {Xing, Shigui and Li, Dongbing and Zhao, Qi},
title = {RPL22L1 is a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma, promoting the growth and metastasis of LUAD cells by inhibiting the MDM2/P53 signaling pathway},
journal = {Aging},
year = {2024},
doi = {10.18632/aging.206096}
}
EUVIMED